Class information for: |
Basic class information |
| Class id | #P | Avg. number of references |
Database coverage of references |
|---|---|---|---|
| 21605 | 413 | 33.9 | 69% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
| Cluster id | Level | Cluster label | #P |
|---|---|---|---|
| 8 | 4 | CARDIAC & CARDIOVASCULAR SYSTEM//PERIPHERAL VASCULAR DISEASES//CARDIOL | 1276458 |
| 11 | 3 | ATRIAL FIBRILLATION//CARDIAC & CARDIOVASCULAR SYSTEM//CATHETER ABLATION | 130936 |
| 822 | 2 | CALCIUM ANTAGONISTS//CALCIUM CHANNEL BLOCKERS//NIFEDIPINE | 11902 |
| 21605 | 1 | POSTINFARCTION ARRHYTHMIAS//SPRINT STUDY GRP//CALCIUM CHANNEL BLOCKERS | 413 |
Terms with highest relevance score |
| rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
|---|---|---|---|---|---|---|
| 1 | POSTINFARCTION ARRHYTHMIAS | authKW | 147869 | 0% | 100% | 2 |
| 2 | SPRINT STUDY GRP | address | 147869 | 0% | 100% | 2 |
| 3 | CALCIUM CHANNEL BLOCKERS | authKW | 119797 | 15% | 3% | 62 |
| 4 | CARDIOVASC MED Y | address | 98578 | 0% | 67% | 2 |
| 5 | 24 HOUR EFFICACY IN REDUCTION OF BLOOD PRESSURE | authKW | 73935 | 0% | 100% | 1 |
| 6 | ACCIDENTAL AND PROGRAMMED CELL DEATH | authKW | 73935 | 0% | 100% | 1 |
| 7 | ADJUNCTIVE MEDICAL THERAPY | authKW | 73935 | 0% | 100% | 1 |
| 8 | AMBULATORY PRESCRIPTIONS | authKW | 73935 | 0% | 100% | 1 |
| 9 | AMER ASSOC CRIT CARE NURSES | address | 73935 | 0% | 100% | 1 |
| 10 | ANTI ISCHAEMIC TREATMENT | authKW | 73935 | 0% | 100% | 1 |
Web of Science journal categories |
| Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
|---|---|---|---|---|---|
| 1 | Cardiac & Cardiovascular System | 4242 | 40% | 0% | 165 |
| 2 | Peripheral Vascular Diseases | 1506 | 18% | 0% | 75 |
| 3 | Medicine, General & Internal | 632 | 19% | 0% | 79 |
| 4 | Pharmacology & Pharmacy | 437 | 21% | 0% | 86 |
| 5 | Public, Environmental & Occupational Health | 60 | 6% | 0% | 26 |
| 6 | Geriatrics & Gerontology | 20 | 1% | 0% | 6 |
| 7 | Oncology | 17 | 6% | 0% | 23 |
| 8 | Primary Health Care | 16 | 1% | 0% | 3 |
| 9 | Toxicology | 8 | 2% | 0% | 9 |
| 10 | Medicine, Research & Experimental | 4 | 2% | 0% | 10 |
Address terms |
| Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
|---|---|---|---|---|---|
| 1 | SPRINT STUDY GRP | 147869 | 0% | 100% | 2 |
| 2 | CARDIOVASC MED Y | 98578 | 0% | 67% | 2 |
| 3 | AMER ASSOC CRIT CARE NURSES | 73935 | 0% | 100% | 1 |
| 4 | CARDIOL L3104 | 73935 | 0% | 100% | 1 |
| 5 | CARDIOPULM CLIN INVEST DEV | 73935 | 0% | 100% | 1 |
| 6 | CARDIOVASC PULM MEMBRANE BIOPHYS | 73935 | 0% | 100% | 1 |
| 7 | CEDAR CANC | 73935 | 0% | 100% | 1 |
| 8 | CLIN EPIDEMTOL BIOSTAT | 73935 | 0% | 100% | 1 |
| 9 | CLIN PHARMACOLCLIN PHARMACOL SERV | 73935 | 0% | 100% | 1 |
| 10 | CLIN ROADM TEAM | 73935 | 0% | 100% | 1 |
Journals |
| Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
|---|---|---|---|---|---|
| 1 | CARDIOVASCULAR DRUGS AND THERAPY | 12351 | 4% | 1% | 18 |
| 2 | PHARMACOEPIDEMIOLOGY AND DRUG SAFETY | 4593 | 3% | 1% | 12 |
| 3 | EUROPEAN HEART JOURNAL | 4561 | 6% | 0% | 25 |
| 4 | JOURNAL OF HUMAN HYPERTENSION | 3396 | 3% | 0% | 13 |
| 5 | JOURNAL OF HYPERTENSION | 3041 | 5% | 0% | 20 |
| 6 | CLINICAL TRIALS AND META-ANALYSIS | 2639 | 0% | 4% | 1 |
| 7 | AMERICAN JOURNAL OF CARDIOLOGY | 2476 | 7% | 0% | 30 |
| 8 | AMERICAN JOURNAL OF HYPERTENSION | 2101 | 3% | 0% | 13 |
| 9 | TOXIC SUBSTANCE MECHANISMS | 997 | 0% | 1% | 1 |
| 10 | KARDIOLOGIYA | 903 | 2% | 0% | 9 |
Author Key Words |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
| Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
|---|---|---|---|---|
| 1 | KIZER, JR , KIMMEL, SE , (2001) EPIDEMIOLOGIC REVIEW OF THE CALCIUM CHANNEL BLOCKER DRUGS - AN UP-TO-DATE PERSPECTIVE OIL THE PROPOSED HAZARDS.ARCHIVES OF INTERNAL MEDICINE. VOL. 161. ISSUE 9. P. 1145 -1158 | 55 | 47% | 35 |
| 2 | GRIMALDI-BENSOUDA, L , KLUNGEL, O , KURZ, X , DE GROOT, MCH , AFONSO, ASM , DE BRUIN, ML , REYNOLDS, R , ROSSIGNOL, M , (2016) CALCIUM CHANNEL BLOCKERS AND CANCER: A RISK ANALYSIS USING THE UK CLINICAL PRACTICE RESEARCH DATALINK (CPRD).BMJ OPEN. VOL. 6. ISSUE 1. P. - | 21 | 72% | 2 |
| 3 | SALTZMAN, BS , WEISS, NS , SIEH, W , FITZPATRICK, AL , MCTIERNAN, A , DALING, JR , LI, CI , (2013) USE OF ANTIHYPERTENSIVE MEDICATIONS AND BREAST CANCER RISK.CANCER CAUSES & CONTROL. VOL. 24. ISSUE 2. P. 365-371 | 19 | 90% | 7 |
| 4 | KIZER, JR , KIMMEL, SE , (2000) THE CALCIUM-CHANNEL BLOCKER CONTROVERSY: HISTORICAL PERSPECTIVE AND IMPORTANT LESSONS FOR FUTURE PHARMACOTHERAPIES. AN INTERNATIONAL SOCIETY OF PHARMACOEPIDEMIOLOGY 'HOT TOPIC'.PHARMACOEPIDEMIOLOGY AND DRUG SAFETY. VOL. 9. ISSUE 1. P. 25 -36 | 38 | 57% | 3 |
| 5 | OPIE, LH , YUSUF, S , KUBLER, W , (2000) CURRENT STATUS OF SAFETY AND EFFICACY OF CALCIUM CHANNEL BLOCKERS IN CARDIOVASCULAR DISEASES: A CRITICAL ANALYSIS BASED ON 100 STUDIES.PROGRESS IN CARDIOVASCULAR DISEASES. VOL. 43. ISSUE 2. P. 171 -196 | 47 | 40% | 37 |
| 6 | YE, X , DU, Q , LI, H , YU, B , ZHAI, Q , (2016) CALCIUM CHANNEL BLOCKERS AND RISK OF BREAST CANCER: A META-ANALYSIS.INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE. VOL. 9. ISSUE 10. P. 20425 -20431 | 22 | 56% | 0 |
| 7 | LI, W , SHI, Q , WANG, WB , LIU, JR , LI, Q , HOU, FG , (2014) CALCIUM CHANNEL BLOCKERS AND RISK OF BREAST CANCER: A META-ANALYSIS OF 17 OBSERVATIONAL STUDIES.PLOS ONE. VOL. 9. ISSUE 9. P. - | 22 | 56% | 3 |
| 8 | WILSON, LE , D'ALOISIO, AA , SANDLER, DP , TAYLOR, JA , (2016) LONG-TERM USE OF CALCIUM CHANNEL BLOCKING DRUGS AND BREAST CANCER RISK IN A PROSPECTIVE COHORT OF US AND PUERTO RICAN WOMEN.BREAST CANCER RESEARCH. VOL. 18. ISSUE . P. - | 17 | 57% | 1 |
| 9 | BEIDERBECK-NOLL, AB , STURKENBOOM, MCJM , VAN DER LINDEN, PD , HERINGS, RMC , HOFMAN, A , COEBERGH, JWW , LEUTKENS, HGM , STRICKER, BHC , (2003) VERAPAMIL IS ASSOCIATED WITH AN INCREASED RISK OF CANCER IN THE ELDERLY: THE ROTTERDAM STUDY.EUROPEAN JOURNAL OF CANCER. VOL. 39. ISSUE 1. P. 98-105 | 19 | 73% | 14 |
| 10 | LI, CI , DALING, JR , TANG, MTC , HAUGEN, KL , PORTER, PL , MALONE, KE , (2013) USE OF ANTIHYPERTENSIVE MEDICATIONS AND BREAST CANCER RISK AMONG WOMEN AGED 55 TO 74 YEARS.JAMA INTERNAL MEDICINE. VOL. 173. ISSUE 17. P. 1629-1637 | 13 | 68% | 35 |
Classes with closest relation at Level 1 |